Meaningful efficacy observed in slow-progressor subgroup; NfL biomarker improvements support potential for accelerated ...

Target ALS, a nonprofit breaking down barriers to amyotrophic lateral sclerosis (ALS) research, has partnered with PacBio , a leading provider of high-quality, highly accurate long read sequencing ...

4 In a patient who presents with symptoms of weakness suggestive of a lower motor neuron (LMN) syndrome ... against the complement component C5 which acts to inhibit the terminal pathway in complement ...

phosphorylated neurofilament heavy chain protein (pNFH), a biomarker indicating the rate of motor neuron damage. In these people, the risk of death at the end of the study was reduced by over 40%. Dr ...

This year’s Malaysia Family Gathering by non-governmental organisation Motor Neuron Disease (MND) Malaysia saw 53 individuals take part in a three-day excursion by train from Kuala Lumpur to ...

A new study from Pitt researchers challenges a decades-old assumption in neuroscience by showing that the brain uses distinct ...

Huang, C. , Xiang, R. and Liu, X. (2025) The Association between Self-Perceived Ageing and Motoric Cognitive Risk Syndrome in Community-Dwelling Older People. Journal of Biosciences and Medicines, 13, ...

A doctor may consider ALS as a possible cause if a person has symptoms and physical examination findings with features of both upper and lower motor neuron disease. There is no cure for ALS ...

1 Brain and Mind Centre, Sydney Medical School, The University of Sydney, Sydney, New South Wales, Australia Lower motor neuron (LMN) syndromes typically present with muscle wasting and weakness and ...